Docstoc

2011-12_Health_PBS_32_NBA

Document Sample
2011-12_Health_PBS_32_NBA Powered By Docstoc
					NATIONAL BLOOD
  AUTHORITY


Agency resources and




                       N
                       B
                       A
planned performance




         671
672
                          National Blood Authority
                                                                 Health and Ageing Portfolio Agency




Section 1: Agency overview and resources
1.1: Strategic Direction Statement ..................................................................... 674
1.2: Agency Resource Statement ...................................................................... 675
1.3: Budget Measures ........................................................................................ 676

Section 2: Outcomes and planned performance
2.1: Outcomes and performance information .................................................... 677

Section 3: Explanatory tables and Budgeted Financial Statements
3.1: Explanatory tables ...................................................................................... 688
3.2: Budgeted Financial Statements .................................................................. 689




                                                                                                                     N
                                                                                                                     B
                                                                                                                     A




                                                      673
NBA – Agency Budget Statements – Agency Overview and Resources



Section 1: Agency Overview and Resources
1.1 Strategic Direction Statement
The Australian Government, through the National Blood Authority (NBA), aims to
ensure that Australia’s blood supply is secure and well managed. The NBA is an
independent statutory agency, established by the Australian Government and state
and territory governments to coordinate policy, governance, funding and
management of the blood banking and plasma product sector in Australia.
The role and functions of the NBA are set out in the National Blood Authority Act
2003. The NBA is prescribed as an agency under the Financial Management and
Accountability Act 1997.




                                        674
                            NBA – Agency Budget Statements – Agency Overview and Resources



1.2 Agency Resources
Table 1.2.1 shows the total resources from all origins. The table summarises how
resources will be applied by outcome and by departmental classifications.
Table 1.2.1 NBA Resource Statement – Budget Estimates for 2011-12 as at Budget
May 2011
                                                   Estim ate Proposed                    Total         Estim ated
                                                    of prior at Budget               estim ate          available
                                              year am ounts                                         appropriation
                                                 available in
                                                     2011-12    2011-12                2011-12             2010-11
                                                        $'000     $'000                  $'000               $'000
Ordinary annual services 1
Departm ental appropriation
 Departmental appropriation2                                     -         5,494          5,494                5,608
 s31 Relevant agency receipts                                    -             -              -                    -
 Total                                                           -         5,494          5,494                5,608
Adm inistered resources 1
 Outcome 1                                                       -         7,679          7,679                5,750
 Total                                                           -         7,679          7,679                5,750
Total ordinary annual services                                   -       13,173          13,173              11,358
Other services - Bill 23
Departm ental non-operating
 Equity injections                                               -               -              -                      -




                                                                                                                           N
                                                                                                                           B
                                                                                                                           A
 Previous years' programs                                        -               -              -                      -
 Total                                                           -               -              -                      -
Total other services                                             -               -              -                      -
Total available annual appropriations                            -       13,173          13,173              11,358
Total appropriations excluding
 Special Accounts                                                -       13,173          13,173              11,358
Special Accounts
 Opening balance4                                       106,296               -        106,296              253,338
 Appropriation receipts 5                                     -          13,173         13,173               11,358
 Appropriation receipts
    - other agencies 6                                           -      646,003        646,003              604,146
 Non-appropriation receipts to
   Special Accounts                                           -        391,197         391,197             357,737
Total Special Accounts                                  106,296      1,050,373       1,156,669           1,226,579
Total resourcing                                        106,296      1,063,546       1,169,842           1,237,937
Less appropriations draw n from annual or
  special appropriations above and credited
  to Special Accounts and/or CAC Act
  bodies through annual appropriations                           -     (13,173)       (13,173)             (11,358)
Total net resourcing for NBA                            106,296      1,050,373       1,156,669           1,226,579
Notes:
All figures are GST exclusive.
1    Appropriation Bill (No.1) 2011-12.
2    Includes an amount of $0.554m in 2011-12 for the Departmental Capital Budgets (refer to Table 3.2.5 for further
     details). For accounting purposes this amount has been designated as ‘contributions by owners’.
3    Appropriation Bill (No.2) 2011-12.
4    Estimated opening balance for special accounts. For further information on special accounts see Table 3.1.2.
5    Appropriation receipts from NBA annual and special appropriations for 2010-11 included above.
6    Appropriation receipts from the Department of Health and Ageing.




                                                         675
NBA – Agency Budget Statements – Agency Overview and Resources



1.3 Budget Measures
Budget Measures relating to the NBA are detailed in Budget Paper No. 2 and are
summarised below.
Table 1.3.1 NBA 2011-12 Budget Measures
                           Program      2010-11     2011-12    2012-13    2013-14    2014-15
                                          $'000       $'000      $'000      $'000      $'000

Cross Portfolio Measures
Health and Ageing Portfolio - adm inistrative efficiencies
National Blood Authority   1.1
 Departmental expenses                    -          -               -        (67)       (27)

Australian Institute of Health and Welfare
 Departmental expenses                        -           -        (15)       (52)       (52)

Australian Organ and Tissue Donation and
 Transplantation Authority
 Departmental expenses                        -           -          -        (18)       (18)

Australian Radiation Protection and Nuclear
 Safety Agency
 Departmental expenses                        -      2,000           -        (76)       (76)

Cancer Australia
 Administered expenses                        -      1,388        810      1,434      1,457
 Departmental expenses                        -          -        297        297        288

Department of Health and Ageing
 Administered expenses                        -     (12,204)   (11,834)   (12,673)   (12,878)
 Departmental expenses                        -      26,281    (14,044)   (30,090)   (38,821)

Food Standards Australia New Zealand
  Departmental expenses                       -           -        (93)     (108)      (108)
National Health and Medical Research Council
 Administered expenses                       -      10,816     11,024     11,239     11,421
 Departmental expenses                       -           -        369        310        310
Professional Services Review
  Departmental expenses                       -          -           -          -        (11)
Total                                         -     28,281     (13,486)   (29,804)   (38,515)

Whole of Government Measures
Efficiency dividend - tem porary increase in the rate
National Blood Authority
  Departmental expenses     1.1           -       (25)             (50)       (63)       (76)
  Departmental capital                    -         (3)             (5)        (6)       (12)
Total                                     -       (28)             (55)       (69)       (88)




                                              676
                      NBA – Agency Budget Statements – Outcomes and Planned Performance



Section 2: Outcomes and Planned Performance
2.1 Outcomes and Performance Information

      Outcome 1 – Access to a secure supply of safe and affordable blood products,
    including through national supply arrangements and coordination of best practice
     standards within agreed funding policies under the national blood arrangements


Outcome Strategy
The Australian Government aims to ensure that the public has access to a secure
and well-managed blood supply. The NBA, on behalf of the Australian
Government and state and territory governments, manages and coordinates blood
supply in Australia in accordance with the National Blood Agreement. The NBA
develops and implements arrangements for the secure supply of safe and
affordable blood products and services, including negotiating and managing
national contracts with suppliers of blood and blood related products. The NBA
will improve the purchasing and supply arrangements for fresh, fractionated and
recombinant products.1 The NBA will also improve long-term planning,
particularly through improved data analysis and stakeholder engagement, to
facilitate the appropriate use of blood products.




                                                                                                        N
                                                                                                        B
                                                                                                        A
Improved clinical usage of blood and blood products remains a key objective,
noting the growing evidence of risk associated with unnecessary transfusions and
the growing cost of the supply of these products. The NBA will facilitate
development and publication of evidence-based national guidelines, informed by
close engagement with clinicians, to raise awareness of the Government’s
stewardship expectations of users of blood and blood products and management
of these products.
The NBA works with governments and stakeholders to implement an efficient
demand-driven structure and a blood supply system that is highly responsive to
needs, based upon evidence and good clinical practice. The NBA also works
collaboratively with stakeholders to ensure that Australia’s blood supply is safe,
secure, adequate and affordable.




1    Fractionated products are those derived from human plasma whereas recombinant products are those
     synthetically derived.


                                                      677
NBA – Agency Budget Statements – Outcomes and Planned Performance



NBA Budgeted Expenses and Resources
Table 2.1.1 provides an overview of the total expenses for NBA by program.
Table 2.1.1: Budgeted Expenses and Resources for NBA
                                           2010-11 2011-12 2012-13     2013-14   2014-15
                                        Estim ated Budget Forw ard Forw ard Forw ard
                                             actual           year 1    year 2    year 3
                                              $'000    $'000   $'000     $'000     $'000
    Program 1.1: National blood agreem ent m anagem ent
    Administered expenses
     Ordinary annual services                 5,750    7,679       -         -         -
       (Appropriation Bill No. 1)
       to the National Blood Authority
         Account                            (5,750)  (7,679)       -         -         -
       to the National Managed Fund (Blood
         and Blood Products) Special
         Account                                  -        -       -         -         -
     Special accounts
       National Blood Authority Account    954,241 ####### 1,101,139 1,192,101 1,292,475
       National Managed Fund (Blood
         and Blood Products) Special
         Account                                  -
                                                  -        -
                                                           -       -
                                                                   -         -
                                                                             -         -
                                                                                       -
    Departmental expenses
     Departmental appropriation1                     5,608        4,940        4,960         4,921        4,999
       To National Blood Authority
         Account                                   (5,608)      (4,940)      (4,960)       (4,921)      (4,999)
     Special Account
       National Blood Authority Account              9,575        9,483        8,349         8,285        8,407
     Expenses not requiring appropriation
       in the budget year 2                              -          617          617           617           621
     Operating deficit (surplus)                     1,343          841           (7)           (7)            -
     Total for Program 1.1                        965,159 ####### 1,110,098 1,200,996 1,301,503
    Total expenses for Outcom e 1                 965,159 ####### 1,110,098 1,200,996 1,301,503

                                                  2010-11      2011-12
    Average staffing level (num ber)                   43           46
1     Departmental appropriation combines ‘Ordinary annual services (Appropriation Bill No 1)’ and ‘Revenue from
      independent sources (s31)’
2     Expenses not requiring appropriation in the budget year is made up of depreciation expense, amortisation
      expense, make good expense and audit fees.




                                                        678
                NBA – Agency Budget Statements – Outcomes and Planned Performance




Program 1.1: National blood agreement management

Program Objectives
Through Program 1.1, the Australian Government aims to:
   ensure the secure supply of all required blood and blood products through
    effective procurement and management of product availability;
   implement blood sector policy and systems to reduce risk and improve
    performance; and
   facilitate appropriate blood management and safe use of blood products for all
    patients.

Major Activities
Secure the supply of blood and blood products
The Australian Government is committed to ensuring the ongoing supply of blood
and blood products. The NBA will achieve this by working with state and territory
governments and suppliers so that requirements for day-to-day product supply
and future demand are well managed.
In 2011-12, the NBA will continue to closely manage blood supply contracts and




                                                                                        N
                                                                                        B
                                                                                        A
ensure the timely transition to all new management arrangements arising from the
2010-11 imported product tender outcomes. In addition, the NBA will monitor the
financial impact for governments and the Australian Red Cross Blood Service (the
Blood Service) of the implementation of the new Output Based Funding Model
with the Blood Service. The new funding model will better link supply
requirements to actual demand ensuring value for money for governments and the
broader community. It will also require hospitals to have greater discipline in their
ordering practices.
The NBA will also implement new contractual arrangements with the Blood
Service for the collection and supply of fresh blood products. The NBA will
monitor the impact of new arrangements as they are agreed and ensure the
associated contractual obligations during the year are achieved by the Blood
Service. The NBA will also work closely with states and territories to finalise and
implement the product payment and substitution rules, the national service
standards and requirements, the national inventory framework, the funding
arrangements for the agreed scope of activities to be delivered through the
transfusion medicine services arm of the Blood Service and the research and
development activities of the Blood Service.
The NBA will also work closely with the Blood Service to monitor the timely
progress of the construction and commissioning of the new principal sites
servicing New South Wales, Australian Capital Territory, Victoria and Tasmania.
This will ensure supply contingency arrangements are in place if unavoidable
slippage in construction occurs. Blood collected by the Blood Service is tested and
treated at principal sites and converted into products for clinical use. Completion
of the development of these new sites will ensure that fresh blood products

                                         679
NBA – Agency Budget Statements – Outcomes and Planned Performance



continue to be provided to the Australian community in the most cost-effective
manner.
The NBA’s contract with CSL Limited provides patients with access to high quality
and cost-effective blood products, such as intravenous immunoglobulin and
albumin, through the ongoing fractionation of plasma collected in Australia. In
2011-12, the NBA will provide advice to the Australian Government and state and
territory governments through the Jurisdictional Blood Committee on applications
for new products that could be supplied under the national blood arrangements.
The NBA is responsible for the procurement of imported intravenous
immunoglobulin products to supplement Australia’s domestic supply. Imported
products account for approximately 20 per cent of Australia’s total intravenous
immunoglobulin requirements for those clinical conditions funded by
governments under the National Blood Agreement. The NBA also supports
cost-effective purchasing of additional intravenous immunoglobulin for other
clinical purposes through standing offer arrangements in each state and territory,
established in conjunction with the NBA’s main imported intravenous
immunoglobulin contracts. In 2011-12, the NBA will oversee and facilitate
transition to new supply arrangements for imported intravenous immunoglobulin
in liaison with the Blood Service and sector stakeholders, which may arise
following the tender process which commenced in 2010-11.
The NBA’s supply responsibilities also include ensuring the supply of specific
clotting factor concentrates for patient use. These concentrates may be produced
(fractionated) from the plasma of blood donors or made synthetically, and are used
to treat patients with inherited and acquired deficiencies of blood clotting factors,
such as patients with Haemophilia A who are deficient in clotting factor VIII.
These treatments are given to patients to control and prevent spontaneous
bleeding, and at times of surgery or trauma. During 2011-12, the NBA will work
with suppliers selected from the previous year’s tender processes to ensure the
continued supply of these products. These new contracts will need to be closely
monitored to ensure that all clinical and user community requirements and needs
are met within agreed contractual timeframes and standards.
Risk management and sector performance improvement
The National Blood Supply Contingency Plan provides the framework for a
national response to a supply disruption or sudden demand increase for example
from a domestic threat or disaster, which affects the provision of a safe and
adequate blood supply. In 2011-12, the NBA will monitor the supply and
inventories of blood and blood products in order to inform activation of the
contingency plan, where necessary. In particular, the NBA will improve the scope
and frequency of data reported to states and territories on inventory matters
through enhanced data capture activities.
During 2010-11, the NBA commenced reviewing the risk management measures
for the secure supply of blood and blood products, including the appropriate level
of national reserve and supplier product inventories. In 2011-12, the NBA will
complete the review and recommend to governments any proposed changes to


                                        680
                       NBA – Agency Budget Statements – Outcomes and Planned Performance



blood and blood product reserve inventories that may be required. Improving
sector performance requires the NBA to understand all facets of collection,
production, distribution and usage of products, as well as monitor supplier
performance. During 2011-12, the NBA will undertake a number of initiatives to
improve blood product use and enhance the overall performance of the sector. The
focus will be on further expanding the range of existing data collection systems
and providing analysis of data from these systems to support blood sector
stakeholders and measure sector performance.
In particular, the NBA will work closely with states and territories and suppliers to
complete the nationwide implementation of BloodNet. BloodNet will provide a
national capability for the electronic ordering and receipting of blood and blood
products. To complement BloodNet, the NBA will explore the scope to implement
interfaces with hospital laboratory information systems and better capture what
happens to products after they are delivered to hospitals. This data will allow for
the identification of potential opportunities for programs to reduce blood and
blood product wastage and inappropriate use.
The NBA will also determine the appropriate next phase of development for the
Australian Bleeding Disorders Registry which captures data on the product
requirements and clinical treatments of people with bleeding disorders. The
registry will enable the NBA to better plan supply requirements and will enable
state and territory governments and haemophilia treatment centres to optimise




                                                                                                                     N
                                                                                                                     B
                                                                                                                     A
treatment regimes for patients. In 2011-12, the NBA will undertake consultations
with the blood sector and the wider health sector to finalise a national performance
scorecard for the blood sector that captures the key outcomes against established
performance criteria for governments, suppliers and end users of products.
In 2011-12, NBA will implement a range of strategies, as agreed by the
Jurisdictional Blood Committee2, to improve the overall performance of the supply
chain, specifically for plasma and recombinant products, so that these products are
managed in a way that is consistent with commercial better practice standards.
This will include reviewing inventory holdings at each point in the supply chain;
exploring options for alternate distribution methods; and confirming with
stakeholders appropriate key performance indicators and standards for delivery
and inventory management.
Appropriate patient blood management and safe use of blood and blood
products
The Australian Government is committed to promoting safe, high quality
management and use of blood and blood related products and services. NBA will
contribute to this by working closely with clinical stakeholders and other experts to
develop clinical practice and product use guidelines. These guidelines will provide
clinicians with consensus and evidence-based information on effective and
appropriate clinical practice.



2   The Jurisdictional Blood Committee is responsible for all jurisdictional issues relating to the national blood
    supply, including planning, production, supply and budgeting.


                                                          681
NBA – Agency Budget Statements – Outcomes and Planned Performance



Following from the successful production of two of six modules of the Patient
Blood Management Guidelines, one of which was published in March 2011 and the
other anticipated at the end of 2011, the NBA will continue to work with relevant
clinical colleges and societies to produce a further two modules for specific patient
populations. The therapeutic approach used in patient blood management
conserves and optimises the individual patient’s own blood, helping to avoid or
reduce the need for transfusion. This optimises the appropriate use of donated
blood and reduces demand on this precious resource. In 2011-12, the NBA will
seek National Health and Medical Research Council approval for a further two
evidence-based modules of the Patient Blood Management Guidelines.
In 2011-12, the NBA will continue to provide secretariat and expert support to the
Patient Blood Management Steering Committee to develop and implement an
appropriate patient blood management program which includes national outcome
measures.
In 2011-12, the review of the Criteria for the Clinical Use of Intravenous
Immunoglobulin in Australia (the Criteria) will be completed. The NBA will closely
monitor the transition to the second edition of the Criteria that will result from the
review. The Criteria will identify the indications for which the therapeutic use of
intravenous immunoglobulin is clinically appropriate and funded under the
National Blood Arrangements. The review has accessed relevant clinical evidence
and expertise to ensure that the Criteria reflect current best practice. In 2011-12, the
NBA will develop an appropriate communication plan to inform the clinical
community of the availability of the second edition.
The NBA’s haemovigilance program focuses on collating and reporting an agreed
set of transfusion-related adverse events. In 2011-12, the NBA will continue to
improve national reporting of adverse transfusion incidents by encouraging all
states and territories to adopt and report against a national data dictionary to
prepare for the publication of the third Australian Haemovigilance Report by June
2013. In addition, the NBA will work closely with clinical stakeholders to progress
clinical initiatives and information provision to reduce the occurrence of and
improve reporting about Transfusion Associated Circulatory Overload and
Transfusion Related Acute Lung Injury - two of the most under-reported adverse
events arising from transfusion.
The use of red cell blood products has been shown to be highly variable with some
patients receiving transfusions which are not required. Information on the use of
these products in hospitals is important for managing supply and demand, and for
identifying appropriate use. Limiting inappropriate use of red blood cells will
enable more efficient use of products whilst improving health outcomes. To
achieve this, the NBA, will produce a national report on the use of red blood cells
in public hospitals around Australia, due for release by June 2012.




                                          682
                      NBA – Agency Budget Statements – Outcomes and Planned Performance



Program 1.1: Deliverables
NBA will produce the following ‘deliverables’ to achieve the objectives of
Program 1.1.
Table 2.1.2: Qualitative Deliverables for Program 1.1



           Qualitative Deliverables                            2011-12 Reference Point or Target



Secure the supply of blood and blood products

New Australian Red Cross Blood Service                    Specific elements of the contractual
contract arrangements are implemented                     arrangements are implemented in
                                                          accordance with the agreed timetable
All new tender outcomes for imported                      Transition arrangements for all elements of
fractionated plasma and recombinant                       contracts are implemented within agreed
products and diagnostic reagent products                  contractual timetables
are implemented3
The Australian Red Cross Blood Service                    The VTPS achieves practical completion by
Victoria and Tasmania principal site (VTPS)               April 2012
achieves practical completion




                                                                                                                   N
                                                                                                                   B
                                                                                                                   A
Risk management and sector performance improvement

Required reserve levels of all products are in            Review completed of appropriate reserve
place                                                     levels for fractionated and recombinant
                                                          products and results are implemented in
                                                          accordance with agreed contractual
                                                          obligations

Appropriate patient blood management and safe use of blood and blood products

Second edition of the Criteria for the use of             Second edition of the Criteria submitted to
Intravenous Immunoglobulin in Australia is                Ministers for approval by June 2012 along
approved by Ministers and a                               with a communications plan
communication plan developed to inform
clinical community of its availability
Produce a report on the use of red blood                  A report on the use of red blood cells in
cells in public hospitals                                 public hospitals is produced by June 2012




3   The primary use of diagnostic reagent products is for immunohaematology testing of patient samples and donor
    blood.


                                                      683
NBA – Agency Budget Statements – Outcomes and Planned Performance



Table 2.1.3: Quantitative Deliverables for Program 1.1

                                     2010-11                             2012-13           2013-14           2014-15
       Quantitative                                    2011-12
                                     Revised                             Forward           Forward           Forward
       Deliverables                                    Budget
                                     Budget                               Year 1            Year 2            Year 3

Secure the supply of blood and blood products

Number of blood
supply contracts                         14                16                16                16                16
managed4

Risk management and sector performance improvement

Percentage of
recommendations from
the Administrative
Review of the National
Blood Arrangements, for                ≥95%              ≥95%              100%              N/A               N/A
which the NBA has
responsibility,
completed within
timeframes5
Percentage of requesting
hospitals provided with
access to BloodNet                     N/A                95%               95%               95%               95%
within agreed
timeframe6

Appropriate patient blood management and safe use of blood and blood products

Number of National
Health and Medical
Research Council
Clinical Practice                         2                 2                 2                 0                 0
Guidelines for Patient
Blood Management
published7




4   The number of blood supply contracts has increased since the 2010-11 Portfolio Budget Statements to meet
    planned procurement arrangements.
5   It is expected that recommendations will be implemented by 2012-13.
6   BloodNet will become operational in 2011-12.
7   A total of six Clinical Practice Guidelines will be developed and published. The deliverable for 2012-13 has been
    increased from the 2010-11 Portfolio Budget Statements.


                                                          684
                 NBA – Agency Budget Statements – Outcomes and Planned Performance



Program 1.1: Key Performance Indicators
The following ‘key performance indicators’ measure the effectiveness of
Program 1.1 in meeting its objectives thereby contributing to the outcome.
Table 2.1.4: Qualitative Key Performance Indicators for Program 1.1



          Qualitative Indicator                  2011-12 Reference Point or Target



Secure the supply of blood and blood products

Management and coordination of Australia’s   High level of satisfaction of all funding
blood supply in accordance with the          jurisdictions with planning, management
National Blood Agreement between the         and coordination of blood supply.
Australian Government and state and          Satisfaction is assessed through survey of
territory governments                        Jurisdictional Blood Committee members

Risk management and sector performance improvement

Management of the National Blood Supply      High level of satisfaction of all funding
Contingency Plan                             jurisdictions with NBA’s management and
                                             implementation as assessed through survey
                                             of Jurisdictional Blood Committee members




                                                                                            N
                                                                                            B
                                                                                            A
Management and support of BloodNet           High level of satisfaction of all funding
                                             jurisdictions and hospitals with NBA’s
                                             management and implementation as
                                             assessed through survey of Jurisdictional
                                             Blood Committee members and hospitals
                                             that have implemented BloodNet

Appropriate patient blood management and safe use of blood and blood products

Quality advice provided to guide promotion   High level of satisfaction of all funding
of safe, high quality patient blood          jurisdictions with NBA’s advice on the
management and use of blood and blood        promotion of patient blood management
related products                             and use of blood and blood related products
                                             as assessed through survey of Jurisdictional
                                             Blood Committee members




                                          685
NBA – Agency Budget Statements – Outcomes and Planned Performance



Table 2.1.5: Quantitative Key Performance Indicators for Program 1.1

                                     2010-11           2011-12          2012-13          2013-14           2014-15
        Quantitative
                                     Revised           Budget           Forward          Forward           Forward
         Indicators
                                     Budget             Target           Year 1           Year 2            Year 3

Secure the supply of blood and blood products

Percentage of
administration costs as a
proportion of the
national supply plan                   <1.4%            <1.4%             <1.4%            <1.4%             <1.4%
budget, under the
National Blood
Agreement
Variance between actual
and NBA estimated total
                                        <5%              <5%               <5%              <5%               <5%
demand for supply of
products

Risk management and sector performance improvement

Number of days the
National Blood Supply
Contingency Plan is                       0                0                 0                0                 0
activated for plasma and
recombinant products8
Percentage of hospitals
                                        N/A               60%              65%              65%               65%
using BloodNet9
Percentage of clotting
factor usage captured in
the Australian Bleeding                 70%               80%              90%              100%             100%
Disorder Register
(ABDR)

Appropriate patient blood management and safe use of blood and blood products

Number of hard copies
distributed and
electronic downloads of
                                         200              200              200               200              200
guidelines and criteria
made available by the
NBA10




8    The National Blood Supply Contingency Plan is only activated in the event that stocks of products are insufficient
     to meet demand. In managing the supply of products, NBA aims to ensure that there is always sufficient stock to
     meet demand.
9    BloodNet will become operational in 2011-12.
10   This Key Performance Indicator has been enhanced to include hardcopy distribution and all NBA electronic
     resources. Electronic resources are available at: <www.nba.gov.au>.


                                                         686
                       NBA – Agency Budget Statements – Outcomes and Planned Performance




                                    2010-11          2011-12        2012-13   2013-14   2014-15
        Quantitative
                                    Revised          Budget         Forward   Forward   Forward
         Indicators
                                    Budget            Target         Year 1    Year 2    Year 3

Number of states and
territories contributing
                                      N/A                   7        N/A         8       N/A
haemovigilance data to
the national report11
Proportion of states and
territories satisfied with
the implementation of
                                      N/A              100%          100%      100%      100%
the Patient Blood
Management
Guidelines12
Number of colleges and
societies that agree to
endorse the Patient                   N/A                   8         10        12        12
Blood Management
modules




                                                                                                  N
                                                                                                  B
                                                                                                  A




11   The Australian Haemovigilance Report is prepared biannually.
12   Implementation strategies commenced in late 2010-11.


                                                       687
NBA – Agency Budget Statements – Budgeted Financial Statements



Section 3: Explanatory Tables and Budgeted Financial
Statements
Section 3 presents explanatory tables and budgeted financial statements which
provide a comprehensive snapshot of agency finances for the 2011-12 Budget year.
It explains how budget plans are incorporated into the financial statements and
provides further details of the reconciliation between appropriations and program
expenses, movements in administered funds, special accounts and government
Indigenous expenditure.

3.1 Explanatory Tables

3.1.1 Movement of administered funds between years
Section 3.1.1 is not applicable to the NBA.

3.1.2 Special Accounts
                                          Opening Appropriation            Other Payments            Closing
                                           balance    receipts          receipts                    balance
                                          2011-12     2011-12           2011-12   2011-12          2011-12
                                          2010-11     2010-11           2010-11   2010-11          2010-11
                             Outcome         $'000       $'000             $'000     $'000             $'000

National Blood Authority         1         98,202            7,679      #######      977,302       149,170
 Account1 (A)                             170,173            5,750      950,588      #######        98,202

National Blood Authority         1           6,872           5,494        3,263        10,675         4,954
 Account1 (D)                                8,716           5,608        3,300        10,752         6,872

National Managed Fund     1
 (Blood and Blood Products)                 1,222                  -     13,346         5,076         9,492
  Special Account2, 3 (A)                  74,449                  -      7,995        81,222         1,222
Total Special Accounts
 2011-12 Estim ate                        106,296          13,173       #######      993,053       163,616
Total Special Accounts
 2010-11 estimate actual                  253,338          11,358       961,883      #######       106,296
Notes:
Other Trust Money - s20 FMA has been abolished.
D = Departmental; A = Administered
1   National Blood Authority Act 2003 - s21 FMA Act
2   s20 FMA Act
3   In 2010-11, the NBA was granted investment powers for the National Managed Fund Special Account. Payments
    represent the purchase of investments.


3.1.3 Australian Government Indigenous Expenditure
In 2011-12, the Australian Government Indigenous Expenditure Statement is not
applicable because the NBA has no specific Indigenous expenses.




                                                     688
                      NBA – Agency Budget Statements – Budgeted Financial Statements




3.2 Budgeted Financial Statements

3.2.1 Differences in Agency Resourcing and Financial Statements
Section 3.2.1 is not applicable to the NBA.
3.2.2 Analysis of Budgeted Financial Statements
An analysis of the NBA’s budgeted financial statements for 2011-12 is provided
below.
Departmental Resources
Comprehensive Income Statement
NBA operational costs are funded jointly by the Australian, State and Territory
Governments on a 63%:37% basis through annual contributions. All NBA receipts
and payments are accounted through special accounts.
NBA operational funding was increased for the four years from 2005-06 to 2008-09
to build capacity, particularly for risk management, information management,
appropriate patient blood management and the safe use of blood and blood
products. While all planned initiatives in these areas are well underway, several
factors have caused the progress of implementation to slip resulting in an
accumulation of funds not yet spent.




                                                                                       N
                                                                                       B
                                                                                       A
Drawing on these accumulated funds to meet the staffing and other costs of
completing these initiatives resulted in operating deficits being budgeted for
2009-10, 2010-11 and 2011-12 and approved by the Minister for Finance and
Deregulation.
With the full implementation of these initiatives by 2012-13, staffing and other
costs will be managed down to the level of funding provided for the NBA’s core
procurement, supply management and contract management activities.
Balance Sheet
Special account accumulated funds are held within the Official Public Account and
included as Receivables in the Balance Sheet. The level of Receivables will fall as
accumulated funds are used to meet expenses in 2011-12. The NBA will maintain
sufficient accumulated funds to cover employee entitlements and other liabilities.
The value of intangible assets will fall over 2011-12 and forward years reflecting
the use and amortisation of the new integrated data management system. Other
non-financial assets and liabilities will remain broadly stable over the period.
Administered Resources
Schedule of Budgeted Income and Expenses Administered on Behalf of Government
The NBA administered accounts include contributions from all states and
territories and the Australian Government for the supply of blood and blood
related products for 2011-12. Each year the Australian Health Ministers’ Council



                                         689
NBA – Agency Budget Statements – Budgeted Financial Statements



approves an Annual National Supply Plan and Budget which is formulated by the
NBA from demand estimates provided by the states and territories.
The 2011-12 Budget for the supply of blood and blood products has increased by
$70.1 million from 2010-11 reflecting increased demand and price rises.
Schedule of Budgeted Assets and Liabilities Administered on Behalf of Government
The schedule of budgeted assets and liabilities administered on behalf of
Government illustrates normal movements in non-financial assets and liabilities.
The increase in Receivables reflects an advance to the Australian Red Cross Blood
Service under the Output Based Funding Model agreement.
During 2010-11, the NBA was granted investment powers for the National
Managed Fund special account. The increase in Investments over the forward
years represents additional contributions received as well as investment income.




                                        690
                       NBA – Agency Budget Statements – Budgeted Financial Statements



3.2.3 Budgeted financial statements tables
Table 3.2.1: Comprehensive income statement (showing net cost of services)
(for the period ended 30 June)
                                    Estim ated  Budget Forw ard Forw ard Forw ard
                                        actual estim ate estim ate estim ate estim ate
                                       2010-11  2011-12   2012-13   2013-14   2014-15
                                         $'000     $'000     $'000     $'000     $'000
EXPENSES
 Employee benefits                      6,261      6,480    4,647     4,596     4,743
 Supplier expenses                      3,677      3,481    3,332     3,319     3,305
 Depreciation and amortisation            980        980      980       980       980
 Total expenses                        10,918     10,941    8,959     8,895     9,028

LESS:
OWN-SOURCE INCOME
 Revenue
   Other revenue                        3,852      4,428    3,274     3,249     3,293
   Total revenue                        3,852      4,428    3,274     3,249     3,293
  Gains
   Other                                  115        115      115       115       115
   Total gains                            115        115      115       115       115
  Total ow n-source incom e             3,967      4,543    3,389     3,364     3,408




                                                                                         N
                                                                                         B
                                                                                         A
Net cost of (contribution by)
 services                               6,951      6,398    5,570     5,531     5,620

  Revenue from Government               5,608      4,940    4,960     4,921     4,999

Surplus (Deficit)                      (1,343)    (1,458)   (610)     (610)     (621)
Surplus (Deficit) attributable to
 the Australian Governm ent            (1,343)    (1,458)   (610)     (610)     (621)

OTHER COMPREHENSIVE INCOME
 Changes in asset revaluation
   reserves                                 -           -       -         -         -
 Total other com prehensive
  incom e                                   -           -       -         -         -
Total com prehensive incom e
 attributable to the
 Australian Governm ent                (1,343)    (1,458)    (610)     (610)     (621)




                                            691
NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.1: Comprehensive income statement (showing net cost of services)
(for the period ended 30 June) (Cont.)
Note: Reconciliation of com prehensive incom e attributable to the agency
                                  2010-11   2011-12    2012-13    2013-14    2014-15
                                     $'000     $'000      $'000      $'000     $'000
Total com prehensive incom e
 (loss) attributable to the
 Australian Governm ent            (1,343)   (1,458)
                                                   0      (610)
                                                              0      (610)
                                                                         0     (621)
                                                                                   0
  plus non-appropriated expenses
    depreciation and amortisation
    expenses                             -      617       617        617          0
                                                                                621
Total com prehensive incom e
 attributable to the agency         (1,343)    (841)         7         7          -




                                         692
                       NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.2: Budgeted departmental balance sheet (as at 30 June)
                                   Estim ated  Budget Forw ard Forw ard Forw ard
                                       actual estim ate estim ate estim ate estim ate
                                      2010-11  2011-12   2012-13   2013-14   2014-15
                                        $'000     $'000     $'000     $'000     $'000
ASSETS
 Financial assets
   Cash and cash equivalents              30        30        30        30        30
   Receivables                         6,955     5,036     4,772     4,900     4,784
   Total financial assets              6,985     5,066     4,802     4,930     4,814
  Non-financial assets
   Land and buildings                    161       232       152        72       992
   Property, plant and equipment         404       287       682       511       165
   Intangibles                         1,440     1,385       879       920       655
   Other                                  57        57        57        57        57
   Total non-financial assets          2,062     1,961     1,770     1,560     1,869
  Total assets                         9,047     7,027     6,572     6,490     6,683

LIABILITIES
  Payables
   Suppliers                             645      644       643        644       644
   Other payables                      1,170        4         6          7         7
   Total payables                      1,815      648       649        651       651
  Provisions




                                                                                        N
                                                                                        B
                                                                                        A
   Employees                           1,342     1,393     1,050     1,090     1,090
   Total provisions                    1,342     1,393     1,050     1,090     1,090
  Total liabilities                    3,157     2,041     1,699     1,741     1,741
Net Assets                             5,890     4,986     4,873     4,749     4,942

EQUITY
 Contributed equity                     812      1,366     1,863     2,349     3,163
 Reserves                               206        206       206       206       206
 Retained surpluses or accumulated
   deficits                            4,872     3,414     2,804     2,194     1,573
 Total equity                          5,890     4,986     4,873     4,749     4,942




                                           693
NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.3: Departmental statement of changes in equity — summary of movement
(Budget year 2011-12)
                                  Retained      Asset     Other Contributed     Total
                                  earnings revaluation reserves      equity/   equity
                                              reserve                capital
                                      $'000      $'000     $'000       $'000    $'000
Opening balance as at 1 July 2011
 Balance carried forw ard from
  previous period                    4,872        206          -        812     5,890
 Surplus (deficit) for the period   (1,458)          -         -           -   (1,458)
 Appropriation (equity injection)         -          -         -           -        -
 Capital budget - Bill 1 (DCB)            -          -         -        554       554
Estim ated closing balance
 as at 30 June 2012                   3,414         206      -        1,366    4,986
DCB = Departmental Capital Budgets.




                                              694
                            NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.4: Budgeted departmental statement of cash flows
(for the period ended 30 June)
                                      Estim ated  Budget Forw ard Forw ard Forw ard
                                          actual estim ate estim ate estim ate estim ate
                                         2010-11  2011-12   2012-13   2013-14   2014-15
                                           $'000     $'000     $'000     $'000     $'000
OPERATING ACTIVITIES
 Cash received
   Appropriations                         5,608      4,940    4,960      4,921     4,999
   Net GST received                         399        379      370        370       370
   Other cash received                    3,297      3,262    3,274      3,251     3,293
   Cash from the Official Public
    Account                               1,664      1,917      261          -       119
   Total cash received                   10,968     10,498    8,865      8,542     8,781
  Cash used
   Employees                              6,474      6,694    5,255      4,821     4,743
   Suppliers                              3,298      3,101    2,949      2,939     3,193
   Net GST paid                             396        378      369        370       370
   Cash to the Official Public
     Account                                  -          -        -        128         -
   Total cash used                       10,168     10,173    8,573      8,258     8,306
  Net cash from (or used by)
   operating activities                     800       325       292       284        475
INVESTING ACTIVITIES




                                                                                             N
                                                                                             B
                                                                                             A
  Cash used
   Purchase of property, plant
     and equipment                          980       879       789       770      1,289
   Total cash used                          980       879       789       770      1,289
  Net cash from (or used by)
   investing activities                    (980)     (879)     (789)      (770)   (1,289)
FINANCING ACTIVITIES
  Cash received
   Capital budget - Bill 1 (DCB)              -       554       497       486        814
   Total cash received                        -       554       497       486        814
  Net cash from (or used by)
   financing activities                       -       554       497       486        814
Net increase (or decrease)
 in cash held                              (180)         -         -         -         -
 Cash and cash equivalents at the
   beginning of the reporting period        210        30        30        30         30
Cash and cash equivalents at the
 end of the reporting period                 30        30        30        30         30
DCB = Departmental Capital Budgets.




                                              695
NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.5: Capital budget statement
                                             Estim ated  Budget Forw ard Forw ard Forw ard
                                                 actual estim ate estim ate estim ate estim ate
                                                2010-11  2011-12   2012-13   2013-14   2014-15
                                                  $'000     $'000     $'000     $'000     $'000
    CAPITAL APPROPRIATIONS
     Capital budget - Bill 1 (DCB)                       -          554           497           486           814
     Total capital appropriations                        -          554           497           486           814
    Total new capital appropriations
     represented by:
     Purchase of non-financial
       assets                                            -          554           497           486           814
     Total item s                                        -          554           497           486           814
    PURCHASE OF NON-FINANCIAL
     ASSETS
     Funded by capital
       appropriation - DCB1                              -          554           497           486           814
     Funded internally from
      departmental resources                          980           325           292           284           475
     Total acquisitions of
      non-financial assets                            980           879           789           770         1,289
    RECONCILIATION OF CASH USED
     TO ACQUIRE ASSETS TO
     ASSET MOVEMENT TABLE
     Total purchases                                  980           879           789           770         1,289
     Total cash used to acquire assets                980           879           789           770         1,289
1     Does not include annual finance lease costs. Includes purchases from current and previous years’ Departmental
      Capital Budgets (DCB).




                                                         696
                                 NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.6: Statement of asset movements (2011-12)

                                                        Buildings Other property Intangibles    Total
                                                                         plant &
                                                                      equipment
                                                             $'000          $'000       $'000    $'000
    As at 1 July 2011
     Gross book value                                             257        793       3,492    4,542
     Accumulated depreciation/amortisation
       and impairment                                              96        389       2,052    2,537

      Opening net book balance                                    161       404        1,440    2,005


    CAP ITAL ASSET ADDITIONS
     Estimated expenditure on new or
      replacement assets
     By purchase - appropriation
      ordinary annual services                                     95         86         183     364
      By purchase - internal
       departmental resources                                      56        147         312      515

    Sub-total                                                     151       233         495      879


    Other movements
     Depreciation/amortisation expense                             80        350         550     980
               1                                                    -          -           -       -
     Disposals
     Other                                                          -          -           -       -




                                                                                                         N
                                                                                                         B
                                                                                                         A
    as at 30 June 2012
      Gross book value                                            408       1,026      3,987    5,421
      Accumulated depreciation/amortisation
        and impairment                                             176       739       2,602    3,517

      Closing net book balance                                    232       287        1,385    1,904
1      Proceeds may be returned to the Official Public Account.




                                                          697
NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.7: Schedule of budgeted income and expenses administered on behalf of
Government (for the period ended 30 June)
                                 Estim ated  Budget Forw ard Forw ard Forw ard
                                     actual estim ate estim ate estim ate estim ate
                                    2010-11  2011-12   2012-13   2013-14   2014-15
                                      $'000     $'000     $'000     $'000     $'000
INCOME ADMINISTERED ON
  BEHALF OF GOVERNMENT
  Revenue
   Non-taxation
     Other sources of non-taxation
      revenues                       959,122 1,034,535 1,113,609 1,204,802 1,305,502
     Total non-taxation              959,122 1,034,535 1,113,609 1,204,802 1,305,502
   Total revenues adm inistered
     on behalf of Governm ent        959,122 1,034,535 1,113,609 1,204,802 1,305,502
  Total incom e adm inistered
   on behalf of Governm ent          959,122 1,034,535 1,113,609 1,204,802 1,305,502
EXPENSES ADMINISTERED ON
 BEHALF OF GOVERNMENT
 Suppliers                           449,150    476,169   513,405   562,210   617,298
 Depreciation and amortisation           115        115       115        99         -
 Grants                              504,976    548,020   587,619   629,792   675,177
 Total expenses adm inistered
   on behalf of Governm ent          954,241 1,024,304 1,101,139 1,192,101 1,292,475




                                          698
                       NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.8: Schedule of budgeted assets and liabilities administered on behalf of
Government (as at 30 June)
                                    Estim ated  Budget Forw ard Forw ard Forw ard
                                        actual estim ate estim ate estim ate estim ate
                                       2010-11  2011-12   2012-13   2013-14   2014-15
                                         $'000     $'000     $'000     $'000     $'000
ASSETS ADMINISTERED ON
 BEHALF OF GOVERNMENT
 Financial assets
   Receivables                         86,121      83,921    84,561    85,319    86,155
   Investments                         81,222      86,298    90,613    95,144    99,901
   Total financial assets             167,343     170,219   175,174   180,463   186,056
  Non-financial assets
   Intangibles                            330         215       100         1         1
   Inventories                         67,212      67,212    67,212    67,212    67,212
   Other                                   12          12        12        12        12
   Total non-financial assets          67,554      67,439    67,324    67,225    67,225
  Total assets adm inistered
   on behalf of Governm ent           234,897     237,658   242,498   247,688   253,281
LIABILITIES ADMINISTERED ON
  BEHALF OF GOVERNMENT
  Interest bearing liabilities
    Payables
      Suppliers                        40,685      84,774    91,357    98,926   107,284




                                                                                          N
                                                                                          B
                                                                                          A
      Total payables                   40,685      84,774    91,357    98,926   107,284
  Total liabilities adm inistered
   on behalf of Governm ent            40,685      84,774    91,357    98,926   107,284




                                            699
NBA – Agency Budget Statements – Budgeted Financial Statements



Table 3.2.9: Schedule of budgeted administered cash flows
(for the period ended 30 June)
                                Estim ated  Budget Forw ard Forw ard Forw ard
                                    actual estim ate estim ate estim ate estim ate
                                   2010-11  2011-12   2012-13   2013-14   2014-15
                                     $'000     $'000     $'000     $'000     $'000
OPERATING ACTIVITIES
 Cash received
   Net GST received                 94,361     101,261   108,833    117,694   127,575
   Other                           354,971     388,526   417,829    451,812   489,321
   Total cash received             449,332     489,787   526,662    569,506   616,896
  Cash used
   Suppliers                          444,948   425,560   506,808   554,629   608,928
   Grant payments                     580,361   548,020   587,619   629,792   675,177
   Cash to the Offical Public Account     721    59,960    14,213    15,080    15,792
   Net GST paid                        94,887   101,846   109,474   118,452   128,411
   Other                                3,000     3,000         -         -         -
   Total cash used                  1,123,917 1,138,386 1,218,114 1,317,953 1,428,308
Net cash from (or used by)
 investing activities            (674,585) (648,599) (691,452) (748,447) (811,412)
INVESTING ACTIVITIES
  Cash used
   Purchase of Investments          81,222       5,076      4,315     4,531     4,757
   Total cash used                  81,222       5,076      4,315     4,531     4,757
Net cash from (or used by)
 investing activities              (81,222)    (5,076)   (4,315)    (4,531)   (4,757)
Net increase (or decrease)
  in cash held                      (755,807) (653,675) (695,767) (752,978) (816,169)
 Cash at beginning of reporting
   period                                   -         -         -         -         -
 Cash from Official Public Account for:
   - special accounts                 750,057   645,996   695,767   752,978   816,169
   - appropriations                     5,750     7,679         -         -         -
Cash at end of reporting period             -         -         -         -         -




                                         700
                      NBA – Agency Budget Statements – Budgeted Financial Statements



3.2.4 Notes to financial statements
The budgeted financial statements for the NBA are prepared for the Budget year,
the previous year and three forward years.
Estimates of special account flows and balances
This table provides for the cash flows and balances of the special accounts under
the responsibility of the NBA.

Departmental Financial Statements
Comprehensive Income Statement (showing net cost of services) (for the period
ended 30 June)
This statement provides a picture of the expected financial results for the NBA by
identifying full accrual expenses and revenues. This highlights whether the NBA is
operating at a sustainable level.
Budgeted departmental balance sheet (as at 30 June)
This statement shows the financial position of the NBA. It enables decision makers
to track the management of the NBA’s assets and liabilities.
Departmental statement of changes in equity – summary of movement (Budget year
2011-2012)
This table shows the movements in equity during the Budget year.




                                                                                       N
                                                                                       B
                                                                                       A
Budgeted departmental statement of cash flows (for the period ended 30 June)
Budgeted cash flows as reflected in the statement of cash flows, provides
important information on the extent and nature of cash flows by characterising
them into expected cash flows from operating activities, investing activities and
financing activities.
Capital budget statement
This table shows the appropriations from Government for the purchase of capital
items and purchases of non-financial assets from capital and internal sources.
Statement of asset movements (2011-12)
This table shows the movements in asset classes through addition (e.g. purchases)
and other movements (e.g. depreciation and amortisation).
Purchases are reconciled in the capital budget statement to the statement of cash
flows as described above and include sources of funding for asset purchases and
include amounts received under net cash resourcing arrangements as also
described above.




                                         701
NBA – Agency Budget Statements – Budgeted Financial Statements




Schedules of Administered Activity
Schedule of budgeted income and expenses administered on behalf of Government
(for the period ended 30 June)
The schedule identifies the revenues and expenses administered by the NBA on
behalf of the Government.
Schedule of budgeted assets and liabilities administered on behalf of Government (as
at 30 June)
The schedule shows the assets and liabilities administered by the NBA on behalf of
the Government.
Schedule of budgeted administered cash flows (for the period ended 30 June)
The schedule shows the cash flows administered by the NBA on behalf of the
Government.




                                        702

				
DOCUMENT INFO